| Print
Arcus Biosciences (RCUS)
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Address
3928 Point Eden Way
Hayward
CA
USA
94545
Telephone
+1 510 694-6200
Forecast key dates
| Name | Key Date |
|---|---|
| Arcus Biosciences Inc Third Quarter Earnings Results for 2026 | 2026-10-28T00:00:00 |
| Arcus Biosciences Inc Second Quarter Earnings Results for 2026 | 2026-08-06T00:00:00 |
| Arcus Biosciences Inc Annual General Meeting for 2026 | 2026-06-10T08:30:00 |
| Arcus Biosciences Inc First Quarter Earnings Conference Call for 2026 | 2026-05-06T16:30:00 |
| Arcus Biosciences Inc First Quarter Earnings Results for 2026 | 2026-05-06T00:00:00 |
| Arcus Biosciences Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-25T13:05:00 |
| Arcus Biosciences Inc Fourth Quarter Earnings Results for 2025 | 2026-02-25T00:00:00 |
| Arcus Biosciences Inc Annual Report for 2025 | 2026-02-18T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.